Call Start 08:00 January 1, 0000 9:04 AM ET

OrthoPediatrics Corp (NASDAQ:KIDS)

Q4 2023 Earnings Conference Call

March 07, 2024 08:00 AM ET

Company Participants

Trip Taylor - Investor Relations

David Bailey - President and CEO

Fred Hite - Chief Operating Officer and CFO

Conference Call Participants

Matthew O'Brien - Piper Sandler

Rick Wise - Stifel

Ryan Zimmerman - BTIG

Dave Turkaly - Citizens JMP

Samuel Brodovsky - Truist Securities

Operator

Good morning and welcome to OrthoPediatrics Corporation's Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are in listen only mode. We'll be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes.

I would like to turn the call over to Trip Taylor from the Gilmartin Group for a few introductory comments.

Trip Taylor

Thank you for joining today's call. With me from the company are David Bailey, President and Chief Executive Officer; and Fred Hite, Chief Operating and Financial Officer.

Before we begin today, let me remind you that the company’s remarks include forward-looking statements within the meaning of federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous risks and uncertainties and the company’s actual results may differ materially. For a discussion of risk factors, I encourage you to review the company’s most recent annual report on Form 10-K, which will be filed with the SEC in the near future.

During the call today, management will also discuss certain non-GAAP financial measures, which are supplemental measures of performance. The company believes these measures provide useful information for investors in evaluating its operations period over period. Each non-GAAP financial measure referenced on this call, the company has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in its earnings release.

Please note that these non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for OrthoPediatrics financial results prepared in accordance with GAAP. In addition, the content of this conference call contains time sensitive information that is accurate only as of the date of this live broadcast today, March 7, 2024. Except as required by law, the company undertakes no obligation to revise or update any statements to reflect events or circumstances taking place after the date of this call.